XML 48 R35.htm IDEA: XBRL DOCUMENT
v3.25.1

Fair Value Measurements (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2025
Fair Value Measurements |
Schedule of fair value on a recurring basis | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | As of
​ | ​ | March 31, 2025
​ | ​ | Fair Value | ​ | Level 1 | ​ | Level 2 | ​ | Level 3 | ​ | Total
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Derivative liability - BTI Warrants | ​ | $ | 3,236 | ​ | $ | — | ​ | $ | 1,834 | ​ | $ | 1,402 | ​ | $ | 3,236
Derivative liability - OnkosXcel Warrants | ​ | ​ | 38 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 38 | ​ | ​ | 38
Total derivative liabilities | ​ | $ | 3,274 | ​ | $ | — | ​ | $ | 1,834 | ​ | $ | 1,440 | ​ | $ | 3,274
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | As of
​ | ​ | December 31, 2024
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Fair Value | ​ | Level 1 | ​ | Level 2 | ​ | Level 3 | ​ | Total
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Derivative liability - BTI Warrants | ​ | $ | 6,593 | ​ | $ | — | ​ | $ | 6,593 | ​ | $ | — | ​ | $ | 6,593
Derivative liability - OnkosXcel Warrants | ​ | ​ | 40 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 40 | ​ | ​ | 40
Total derivative liabilities | ​ | $ | 6,633 | ​ | $ | — | ​ | $ | 6,593 | ​ | $ | 40 | ​ | $ | 6,633
Schedule of changes in Level 3 liabilities | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three months ended
​ | ​ | March 31,
​ | ​ | 2025 | ​ | 2024
​ | ​ | ​ | ​ | ​ | ​ | ​
Derivative liabilities, Balance - January 1 | ​ | $ | 40 | ​ | $ | 1,905
Addition of derivative liabilities - BTI Warrant (March 2025 Accompanying Warrants) | ​ | ​ | 2,831 | ​ | ​ | —
Addition of derivative liabilities - Option Warrant | ​ | ​ | 369 | ​ | ​ | —
Termination of derivative liabilities - Option Warrant | ​ | ​ | (369) | ​ | ​ | —
Change in fair value | ​ | ​ | (1,431) | ​ | ​ | (88)
Derivative liabilities, Balance - March 31 | ​ | $ | 1,440 | ​ | $ | 1,817
Schedule of warrants outstanding | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Warrant Recipient | ​ | Warrant Type | ​ | Issue Date | ​ | Exercise Price | ​ | Number of Warrants | ​ | Classification
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Lenders and RIFA Purchasers | ​ | Closing Date Warrants | ​ | 4/19/2022 | ​ | $ | 7.68 | ​ | 17 | ​ | Equity
Lenders and RIFA Purchasers | ​ | 2023 Warrants | ​ | 12/5/2023 | ​ | $ | 7.68 | ​ | 4 | ​ | Equity
Lenders and RIFA Purchasers | ​ | 2024 Warrants | ​ | 3/20/2024 | ​ | $ | 7.68 | ​ | 6 | ​ | Equity
Lenders and RIFA Purchasers | ​ | New Warrants | ​ | 11/25/2024 | ​ | $ | 0.16 | ​ | 313 | ​ | Equity
Armistice Capital Master Fund Ltd. | ​ | Accompanying Warrants | ​ | 3/25/2024 | ​ | $ | 9.136 | ​ | 534 | ​ | Derivative Liability
Armistice Capital Master Fund Ltd. | ​ | Accompanying Warrants | ​ | 3/25/2024 | ​ | $ | 51.20 | ​ | 5 | ​ | Derivative Liability
Armistice Capital Master Fund Ltd. | ​ | November 2024 Accompanying Warrants | ​ | 11/25/2024 | ​ | $ | 7.68 | ​ | 846 | ​ | Derivative Liability
Heights Capital Management | ​ | November 2024 Accompanying Warrants | ​ | 11/25/2024 | ​ | $ | 7.68 | ​ | 27 | ​ | Derivative Liability
Hudson Bay Capital Management | ​ | November 2024 Accompanying Warrants | ​ | 11/25/2024 | ​ | $ | 7.68 | ​ | 27 | ​ | Derivative Liability
IntraCoastal Capital, LLC | ​ | November 2024 Accompanying Warrants | ​ | 11/25/2024 | ​ | $ | 7.68 | ​ | 13 | ​ | Derivative Liability
Murchison Capital Partners, LP | ​ | March 2025 Accompanying Warrants | ​ | 3/4/2025 | ​ | $ | 4.20 | ​ | 4,000 | ​ | Derivative Liability
Total warrants issued | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 5,792 | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration